The Zinc-Dependent Protease Activity of the Botulinum Neurotoxins

The botulinum neurotoxins (BoNT, serotypes A-G) are some of the most toxic proteins known and are the causative agents of botulism. Following exposure, the neurotoxin binds and enters peripheral cholinergic nerve endings and specifically and selectively cleaves one or more SNARE proteins to produce flaccid paralysis. This review centers on the kinetics of the Zn-dependent proteolytic activities of these neurotoxins, and briefly describes inhibitors, activators and factors underlying persistence of toxin action. Some of the structural, enzymatic and inhibitor data that are discussed here are available at the botulinum neurotoxin resource, BotDB (http://botdb.abcc.ncifcrf.gov).

[1]  L. Simpson.  Pharmacological studies on the subcellular site of action of botulinum toxin type A. , 1978, The Journal of pharmacology and experimental therapeutics.

[2]  B. Roques,et al.  Solid-phase synthesis, conformational analysis and in vitro cleavage of synthetic human synaptobrevin II 1-93 by tetanus toxin L chain. , 1994, European journal of biochemistry.

[3]  L. Simpson,et al.  Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins. , 1994, The Journal of pharmacology and experimental therapeutics.

[4]  S. Swaminathan,et al.  A novel mechanism for Clostridium botulinum neurotoxin inhibition. , 2002, Biochemistry.

[5]  R. Stevens,et al.  Crystal structure of botulinum neurotoxin type A and implications for toxicity , 1998, Nature Structural Biology.

[6]  K. Janda,et al.  Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A's zinc endopeptidase. , 2010, Bioorganic & medicinal chemistry letters.

[7]  H. Shukla,et al.  Protein Domain Analysis of C. botulinum Type A Neurotoxin and Its Relationship with Other Botulinum Serotypes , 2009, Toxins.

[8]  H. Bigalke,et al.  Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum a toxin , 1980, Naunyn-Schmiedeberg's Archives of Pharmacology.

[9]  J. Brown,et al.  Clostridial Neurotoxins and Substrate Proteolysis in Intact Neurons , 1996, The Journal of Biological Chemistry.

[10]  Rick Gussio,et al.  A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloprotease. , 2007, Journal of medicinal chemistry.

[11]  F. Gomis-Rüth,et al.  Structural aspects of the metzincin clan of metalloendopeptidases , 2003, Molecular biotechnology.

[12]  N. Fairweather,et al.  A single mutation in the recombinant light chain of tetanus toxin abolishes its proteolytic activity and removes the toxicity seen after reconstitution with native heavy chain. , 1994, Biochemistry.

[13]  A. Cornish-Bowden.  Fundamentals of Enzyme Kinetics , 1979 .

[14]  S. Nauenburg,et al.  Disassembly of the reconstituted synaptic vesicle membrane fusion complex in vitro. , 1995, The EMBO journal.

[15]  A. Bairoch,et al.  A unique signature identifies a family of zinc‐dependent metallopeptidases , 1989, FEBS letters.

[16]  A. Ferrer-Montiel,et al.  Tyrosine Phosphorylation Modulates the Activity of Clostridial Neurotoxins* , 1996, The Journal of Biological Chemistry.

[17]  Lisa M Eubanks,et al.  Identification of a botulinum neurotoxin A protease inhibitor displaying efficacy in a cellular model. , 2006, Chemical communications.

[18]  J. Jankovic,et al.  Long‐term botulinum toxin efficacy, safety, and immunogenicity , 2005, Movement disorders : official journal of the Movement Disorder Society.

[19]  T. Tzanov,et al.  Studies of stabilization of native catalase using additives , 2002 .

[20]  K. Janda,et al.  Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate. , 2006, Biochemistry.

[21]  Stewart‐Tull.  Toxins , 1998 .

[22]  Yuan-Ping Pang,et al.  Potent New Small-Molecule Inhibitor of Botulinum Neurotoxin Serotype A Endopeptidase Developed by Synthesis-Based Computer-Aided Molecular Design , 2009, PloS one.

[23]  L. Simpson,et al.  Identification of the major steps in botulinum toxin action. , 2004, Annual review of pharmacology and toxicology.

[24]  Mauricio Montal,et al.  Botulinum neurotoxin: a marvel of protein design. , 2010, Annual review of biochemistry.

[25]  Axel T. Brunger,et al.  Substrate recognition strategy for botulinum neurotoxin serotype A , 2004, Nature.

[26]  L. Simpson.  Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins. , 1988, The Journal of pharmacology and experimental therapeutics.

[27]  N. Oppenheimer,et al.  Structure and mechanism , 1989 .

[28]  C. Shone,et al.  Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin. , 1994, European journal of biochemistry.

[29]  S. Turcaud,et al.  Metallopeptidase inhibitors of tetanus toxin: A combinatorial approach. , 1999, Journal of medicinal chemistry.

[30]  E. Habermann,et al.  Evidence for a link between specific proteolysis and inhibition of [3H]-noradrenaline release by the light chain of tetanus toxin , 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.

[31]  S. Nauenburg,et al.  Proteolysis of SNAP‐25 Isoforms by Botulinum Neurotoxin Types A, C, and E , 1999, Journal of neurochemistry.

[32]  Secondary structural predictions for the clostridial neurotoxins , 1994, Proteins.

[33]  Daniel E Koshland.  The application and usefulness of the ratio k(cat)/K(M). , 2002, Bioorganic chemistry.

[34]  K. Inouye,et al.  Effects of introducing negative charges into the molecular surface of thermolysin by site-directed mutagenesis on its activity and stability. , 2008, Biochimica et biophysica acta.

[35]  G. Oyler,et al.  Persistence of botulinum neurotoxin action in cultured spinal cord cells 1,2 , 1999, FEBS letters.

[36]  S. Swaminathan,et al.  Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B , 2000, Nature Structural Biology.

[37]  C. Frassoni,et al.  Entering neurons: botulinum toxins and synaptic vesicle recycling , 2006, EMBO reports.

[38]  Frank J. Lebeda,et al.  Onset dynamics of type A botulinum neurotoxin-induced paralysis , 2008, Journal of Pharmacokinetics and Pharmacodynamics.

[39]  R. Ellis.  Macromolecular crowding : obvious but underappreciated , 2022 .

[40]  D. Rich,et al.  Synthesis of substrates and inhibitors of botulinum neurotoxin type A metalloprotease. , 2008, The journal of peptide research : official journal of the American Peptide Society.

[41]  D. Read,et al.  Botulinum versus tetanus neurotoxins: why is botulinum neurotoxin but not tetanus neurotoxin a food poison? , 1995, Toxicon : official journal of the International Society on Toxinology.

[42]  S. Marcus.  Reflections on the care of a patient severely poisoned by 'rogue' botulinum toxin and rendered paralysed for a protracted hospital stay , 2009 .

[43]  J. Dolly,et al.  Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments. , 1994, Biochemistry.

[44]  G. Schiavo,et al.  Neurotoxins affecting neuroexocytosis. , 2000, Physiological reviews.

[45]  B. Roques,et al.  Inhibition of Neurotransmitter Release by Synthetic Proline-rich Peptides Shows That the N-terminal Domain of Vesicle-associated Membrane Protein/Synaptobrevin Is Critical for Neuro-exocytosis (*) , 1995, The Journal of Biological Chemistry.

[46]  N. Hooper,et al.  Families of zinc metalloproteases , 1994, FEBS letters.

[47]  M. Adler,et al.  A study of zinc-dependent metalloendopeptidase inhibitors as pharmacological antagonists in botulinum neurotoxin poisoning. , 1995, Toxicon : official journal of the International Society on Toxinology.

[48]  M. Morales,et al.  Analytical description of the effects of modifiers and of enzyme multivalency upon the steady state catalyzed reaction rate , 1953 .

[49]  Helen Ho,et al.  Plasma membrane localization signals in the light chain of botulinum neurotoxin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Adler,et al.  Efficacy of certain quinolines as pharmacological antagonists in botulinum neurotoxin poisoning. , 1997, Toxicon : official journal of the International Society on Toxinology.

[51]  Y. Dunant,et al.  Tetanus and botulinum toxins block the release of acetylcholine from slices of rat striatum and from the isolated electric organ of Torpedo at different concentrations. , 1988, Toxicon : official journal of the International Society on Toxinology.

[52]  V. Tugnoli,et al.  On the action of botulinum neurotoxins A and E at cholinergic terminals , 1998, Journal of Physiology-Paris.

[53]  C. Montecucco,et al.  The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity. , 2009, Molecular aspects of medicine.

[54]  Philip K. Russell,et al.  Botulinum toxin as a biological weapon: medical and public health management. , 2001, JAMA.

[55]  H. Sarkar,et al.  Enhancement of the endopeptidase activity of botulinum neurotoxin by its associated proteins and dithiothreitol. , 1999, Biochemistry.

[56]  G. Schiavo,et al.  Botulinum neurotoxins are zinc proteins. , 1992, The Journal of biological chemistry.

[57]  J. Alves,et al.  Arg(362) and Tyr(365) of the botulinum neurotoxin type a light chain are involved in transition state stabilization. , 2002, Biochemistry.

[58]  Regina Z. Cer,et al.  IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding , 2009, Nucleic Acids Res..

[59]  J. Dolly,et al.  Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. , 1996, Biochemistry.

[60]  M. Adler,et al.  Protection by the heavy metal chelator N,N,N',N'-tetrakis (2-pyridylmethyl)ethylenediamine (TPEN) against the lethal action of botulinum neurotoxin A and B. , 1997, Toxicon : official journal of the International Society on Toxinology.

[61]  G. Schiavo,et al.  Common and distinct fusion proteins in axonal growth and transmitter release , 1996, The Journal of comparative neurology.

[62]  J. Dolly,et al.  Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation , 2003, Molecular and Cellular Neuroscience.

[63]  B. Poulain,et al.  How do the Botulinum Neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action , 2008 .

[64]  D. Koshland.  Application of a Theory of Enzyme Specificity to Protein Synthesis. , 1958, Proceedings of the National Academy of Sciences of the United States of America.

[65]  Michel Schneider,et al.  Collaborative annotation of genes and proteins between UniProtKB/Swiss-Prot and dictyBase , 2009, Database J. Biol. Databases Curation.

[66]  L. Simpson.  Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins. , 1983, The Journal of pharmacology and experimental therapeutics.

[67]  Y. Kamata,et al.  Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin. , 1991, The Journal of pharmacology and experimental therapeutics.

[68]  Joseph Jankovic,et al.  Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson’s disease , 2007, Expert review of neurotherapeutics.

[69]  R. Stephens,et al.  Temporal characteristics of botulinum neurotoxin therapy , 2010, Expert review of neurotherapeutics.

[70]  A. Fersht.  Structure and mechanism in protein science , 1998 .

[71]  K. Bostian,et al.  Endoproteinase Activity of Type A Botulinum Neurotoxin: Substrate Requirements and Activation by Serum Albumin , 1997, Journal of protein chemistry.

[72]  N. Fairweather,et al.  The complete nucleotide sequence of tetanus toxin. , 1986, Nucleic acids research.

[73]  L. Simpson.  The interaction between aminoquinolines and presynaptically acting neurotoxins. , 1982, The Journal of pharmacology and experimental therapeutics.

[74]  M. Adler,et al.  Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle. , 2001, Toxicon : official journal of the International Society on Toxinology.

[75]  T. Südhof,et al.  Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. , 1994, The Journal of biological chemistry.

[76]  A. Brunger,et al.  A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformation than SNAP-25 substrate. , 2008, Structure.

[77]  K. Janda,et al.  Botulinum neurotoxin A protease: discovery of natural product exosite inhibitors. , 2010, Journal of the American Chemical Society.

[78]  G. Fernández-Ballester,et al.  Modulation of botulinum neurotoxin A catalytic domain stability by tyrosine phosphorylation , 2004, FEBS letters.

[79]  T. Südhof,et al.  Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. , 1994, The Journal of biological chemistry.

[80]  F. Benfenati,et al.  Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc. , 1992, EMBO Journal.

[81]  J. Dolly,et al.  Persistence of the synaptosomal‐associated protein‐25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment , 2007, BJU international.

[82]  R. Wait,et al.  Proteolytic cleavage of synthetic fragments of vesicle-associated membrane protein, isoform-2 by botulinum type B neurotoxin. , 1993, European journal of biochemistry.

[83]  F. Lebeda,et al.  Antagonism of botulinum toxin-induced muscle weakness by 3,4-diaminopyridine in rat phrenic nerve-hemidiaphragm preparations. , 1995, Toxicon : official journal of the International Society on Toxinology.

[84]  F. Benfenati,et al.  Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin , 1992, Nature.

[85]  F. Lebeda,et al.  Membrane Channel activity and Translocation of Tetanus and Botulinum Neurotoxins , 1999 .

[86]  Neil D. Rawlings,et al.  MEROPS: the peptidase database , 2009, Nucleic Acids Res..

[87]  V. Sathyamoorthy,et al.  Separation, purification, partial characterization and comparison of the heavy and light chains of botulinum neurotoxin types A, B, and E. , 1985, The Journal of biological chemistry.

[88]  M. Adler,et al.  Evaluation of phosphoramidon and three synthetic phosphonates for inhibition of botulinum neurotoxin B catalytic activity , 1999, Journal of Applied Toxicology.

[89]  L. Simpson.  Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. , 1980, The Journal of pharmacology and experimental therapeutics.

[90]  Axel T Brunger,et al.  Botulinum Neurotoxin Heavy Chain Belt as an Intramolecular Chaperone for the Light Chain , 2007, PLoS pathogens.

[91]  K. Bostian,et al.  Proteolysis of synthetic peptides by type A botulinum neurotoxin , 1995, Journal of protein chemistry.

[92]  L. Simpson.  A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism , 1986, Infection and immunity.

[93]  Amos Bairoch,et al.  PROSITE, a protein domain database for functional characterization and annotation , 2009, Nucleic Acids Res..

[94]  J. P. Kennedy,et al.  Superactivation of the botulinum neurotoxin serotype A light chain metalloprotease: a new wrinkle in botulinum neurotoxin. , 2006, Journal of the American Chemical Society.

[95]  Free-energy contributions to complex formation between botulinum neurotoxin type B and synaptobrevin fragment. , 2002, Protein engineering.

[96]  C. Montecucco,et al.  Peculiar binding of botulinum neurotoxins. , 2007, ACS chemical biology.

[97]  D. Boger,et al.  An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists , 2007, Proceedings of the National Academy of Sciences.

[98]  G. Schiavo,et al.  Structure and function of tetanus and botulinum neurotoxins , 1995, Quarterly Reviews of Biophysics.

[99]  J. Dolly,et al.  Rescue of Exocytosis in Botulinum Toxin A-poisoned Chromaffin Cells by Expression of Cleavage-resistant SNAP-25 , 1999, The Journal of Biological Chemistry.